These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 36805918)
1. HER2 as a potential therapeutic target on quiescent prostate cancer cells. Yumoto K; Rashid J; Ibrahim KG; Zielske SP; Wang Y; Omi M; Decker AM; Jung Y; Sun D; Remmer HA; Mishina Y; Buttitta LA; Taichman RS; Cackowski FC Transl Oncol; 2023 May; 31():101642. PubMed ID: 36805918 [TBL] [Abstract][Full Text] [Related]
2. Tamoxifen overcomes the trastuzumab-resistance of SK-BR-3 tumorspheres by targeting crosstalk between cytoplasmic estrogen receptor α and the EGFR/HER2 signaling pathway. Kwon YS; Nam KS; Kim S Biochem Pharmacol; 2021 Aug; 190():114635. PubMed ID: 34058187 [TBL] [Abstract][Full Text] [Related]
3. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
4. SNHG1 opposes quiescence and promotes docetaxel sensitivity in prostate cancer. Zielske SP; Chen W; Ibrahim KG; Cackowski FC BMC Cancer; 2023 Jul; 23(1):672. PubMed ID: 37464317 [TBL] [Abstract][Full Text] [Related]
6. Safrana l Prevents Prostate Cancer Recurrence by Blocking the Re-activation of Quiescent Cancer Cells Jiang X; Li Y; Feng JL; Nik Nabil WN; Wu R; Lu Y; Liu H; Xi ZC; Xu HX Front Cell Dev Biol; 2020; 8():598620. PubMed ID: 33392189 [TBL] [Abstract][Full Text] [Related]
7. Tumor removal limits prostate cancer cell dissemination in bone and osteoblasts induce cancer cell dormancy through focal adhesion kinase. Liu R; Su S; Xing J; Liu K; Zhao Y; Stangis M; Jacho DP; Yildirim-Ayan ED; Gatto-Weis CM; Chen B; Li X J Exp Clin Cancer Res; 2023 Oct; 42(1):264. PubMed ID: 37821954 [TBL] [Abstract][Full Text] [Related]
8. Visualization of endogenous p27 and Ki67 reveals the importance of a c-Myc-driven metabolic switch in promoting survival of quiescent cancer cells. La T; Chen S; Guo T; Zhao XH; Teng L; Li D; Carnell M; Zhang YY; Feng YC; Cole N; Brown AC; Zhang D; Dong Q; Wang JY; Cao H; Liu T; Thorne RF; Shao FM; Zhang XD; Jin L Theranostics; 2021; 11(19):9605-9622. PubMed ID: 34646389 [No Abstract] [Full Text] [Related]
9. Cellular dormancy in minimal residual disease following targeted therapy. Ruth JR; Pant DK; Pan TC; Seidel HE; Baksh SC; Keister BA; Singh R; Sterner CJ; Bakewell SJ; Moody SE; Belka GK; Chodosh LA Breast Cancer Res; 2021 Jun; 23(1):63. PubMed ID: 34088357 [TBL] [Abstract][Full Text] [Related]
10. Abscisic acid regulates dormancy of prostate cancer disseminated tumor cells in the bone marrow. Jung Y; Cackowski FC; Yumoto K; Decker AM; Wang Y; Hotchkin M; Lee E; Buttitta L; Taichman RS Neoplasia; 2021 Jan; 23(1):102-111. PubMed ID: 33296752 [TBL] [Abstract][Full Text] [Related]